Steiner Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Chandigarh, Chandigarh, India, established in 2013.
2013 Chandigarh, Chandigarh, India Struck Off
Last Updated:
Access Report
About Steiner Pharma Private Limited

Steiner Pharma Private Limited, a struck off private limited company, was established on 26 September 2013 in Chandigarh, Chandigarh, India. Engaging in medicinal chemical & botanical products within the chemicals sector, it holds CIN: U24232CH2013PTC034744. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.25 M and a paid-up capital of ₹0.10 M.

Its leadership includes Gauri Shankar Vashista (Director), Kamalesh Rachna Vashistha (Director). Its latest AGM occurred on 30 September 2015, with the balance sheet filed on 31 March 2015. It is based at 175, Phase I Industrial & Business Park, Chandigarh, Chandigarh, 160002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232CH2013PTC034744

  • Registration Number

    034744

  • Incorporation Date

    26 September 2013

  • Authorized Capital

    ₹0.25 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.25 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 5 Months
  • Last Filing with ROC 31 Mar 2015
Company report

Steiner Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Steiner Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Steiner Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Gauri Shankar Vashista Director 26 Sep 2013 Current
Kamalesh Rachna Vashistha Director 26 Sep 2013 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Steiner Pharma.

Enhance accessibility to Steiner Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Steiner Pharma revenue growth over time
Steiner Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Steiner Pharma?

Unlock access to Steiner Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Steiner Pharma?

Unlock and access historical data on people associated with Steiner Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Steiner Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Steiner Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Steiner Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Steiner Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records. was completed.

  • Balance Sheet

    Steiner Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Chandigarh. was recorded as a recent event.

  • Director Appointment

    The activity Gauri Shankar Vashista was appointed as a Director was appointed as a Director on 26 Sep 2013 & has been associated with this company since 12 years 5 months . was completed.

  • Director Appointment

    The activity Kamalesh Rachna Vashistha was appointed as a Director was appointed as a Director on 26 Sep 2013 & has been associated with this company since 12 years 5 months . was completed.

  • Company Incorporation

    Progress on Steiner Pharma Private Limited was registered on 26 Sep 2013 with Roc Chandigarh & aged 12 years 5 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Steiner Pharma Private Limited?

The CIN of Steiner Pharma Private Limited is U24232CH2013PTC034744.

Where is Steiner Pharma Private Limited headquartered?

Steiner Pharma Private Limited is headquartered at 175, Phase I Industrial & Business Park, Chandigarh, Chandigarh, 160002.

When was Steiner Pharma Private Limited incorporated?

Steiner Pharma Private Limited was incorporated on 26 September 2013.

Who are the current directors of Steiner Pharma Private Limited?

The current directors of Steiner Pharma Private Limited are

What is the primary industry of Steiner Pharma Private Limited?

The primary industry of Steiner Pharma Private Limited is Chemicals.

Is Steiner Pharma Private Limited a listed company?

Steiner Pharma Private Limited is unlisted.

What is the capital structure of Steiner Pharma Private Limited?

The authorized capital of Steiner Pharma Private Limited is ₹0.25 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available